胃肠间质瘤-话题@MedSci

#胃肠间质瘤#

7篇内容 | 1274人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183305, encodeId=fb872183305e1, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=97b783362ae' target=_blank style='color:#2F92EE;'>#胃肠间质瘤#</a> <a href='/topic/show?id=1f42110409d9' target=_blank style='color:#2F92EE;'>#NTRK3#</a>, objectTitle=“绘”解读真报告丨胃肠间质瘤患者检出NTRK3融合，实体瘤1299基因助力临床诊疗, objectType=article, longId=810382, objectId=a15b8103829b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-at-work-PGMH47J.jpg, objectUrl=/article/show_article.do?id=a15b8103829b, replyNumber=0, likeNumber=22, createdTime=2024-01-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a15b8103829b, moduleTitle=“绘”解读真报告丨胃肠间质瘤患者检出NTRK3融合，实体瘤1299基因助力临床诊疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a15b8103829b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2130060, encodeId=ce9121300604d, content=瑞培替尼治疗3次或以上治疗后的晚期<a href='/topic/show?id=97b783362ae' target=_blank style='color:#2F92EE;'>#胃肠间质瘤#</a>, objectTitle=2023 NICE 技术鉴定指导意见：瑞培替尼治疗3次或以上治疗后的晚期胃肠道间质瘤[TA881], objectType=guider, longId=23850, objectId=10fe61c003121108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=10fe61c003121108, replyNumber=0, likeNumber=46, createdTime=2023-05-04, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=10fe61c003121108, moduleTitle=2023 NICE 技术鉴定指导意见：瑞培替尼治疗3次或以上治疗后的晚期胃肠道间质瘤[TA881], moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=10fe61c003121108)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2126279, encodeId=66ba21262e96c, content=基于STATs磷酸化诱导TAMs重塑探究<a href='/topic/show?id=2bbf10319ec5' target=_blank style='color:#2F92EE;'>#黄芪多糖#</a>协同<a href='/topic/show?id=01a536491b9' target=_blank style='color:#2F92EE;'>#卡博替尼#</a>抗<a href='/topic/show?id=97b783362ae' target=_blank style='color:#2F92EE;'>#胃肠间质瘤#</a>耐药机制 , objectTitle=基于STATs磷酸化诱导TAMs重塑探究黄芪多糖协同卡博替尼抗胃肠间质瘤耐药机制, objectType=nsfc, longId=1044299, objectId=b11f104429993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/sci/nsfc_show.do?id=b11f104429993, replyNumber=0, likeNumber=51, createdTime=2023-04-16, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=香港, moduleDTOList=[ModuleDTO(moduleId=b11f104429993, moduleTitle=基于STATs磷酸化诱导TAMs重塑探究黄芪多糖协同卡博替尼抗胃肠间质瘤耐药机制, moduleType=nsfc, hrefUrl=https://www.medsci.cn/sci/nsfc_show.do?id=b11f104429993)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1242668, encodeId=b57412426689f, content=<a href='/topic/show?id=97b783362ae' target=_blank style='color:#2F92EE;'>#胃肠间质瘤#</a>, objectTitle=田艳涛：2022版胃肠间质瘤指南解读, objectType=open_course, longId=2353, objectId=2353, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220901/1662027517890_6459136.jpg, objectUrl=https://open.medsci.cn/study/703d602353608, replyNumber=0, likeNumber=24, createdTime=2022-09-02, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=703d602353608, moduleTitle=田艳涛：2022版胃肠间质瘤指南解读, moduleType=open_course, hrefUrl=https://open.medsci.cn/study/703d602353608)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1241281, encodeId=b297124128189, content=<a href='/topic/show?id=edba4069ec' target=_blank style='color:#2F92EE;'>#CAR-T治疗#</a><a href='/topic/show?id=f11ae42016b' target=_blank style='color:#2F92EE;'>#神经内分泌肿瘤#</a>和<a href='/topic/show?id=97b783362ae' target=_blank style='color:#2F92EE;'>#胃肠间质瘤#</a>的安全靶点——CDH17（LI<a href='/topic/show?id=57639636945' target=_blank style='color:#2F92EE;'>#钙粘蛋白#</a>）, objectTitle=Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）, objectType=article, longId=723586, objectId=f925e23586f7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220405/a3850022b8c5433ba11d6b816bfa2a4b.jpg, objectUrl=/article/show_article.do?id=f925e23586f7, replyNumber=0, likeNumber=96, createdTime=2022-08-27, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f925e23586f7, moduleTitle=Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f925e23586f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241282, encodeId=b7c1124128212, content=<a href='/topic/show?id=97b783362ae' target=_blank style='color:#2F92EE;'>#胃肠间质瘤#</a>, objectTitle=胃肠间质瘤基因检测与临床应用的中国专家共识(2021版), objectType=guider, longId=15301, objectId=e12b41c0022662ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=e12b41c0022662ae, replyNumber=0, likeNumber=56, createdTime=2022-08-27, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e12b41c0022662ae, moduleTitle=胃肠间质瘤基因检测与临床应用的中国专家共识(2021版), moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=e12b41c0022662ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241277, encodeId=a98112412e752, content=<a href='/topic/show?id=97b783362ae' target=_blank style='color:#2F92EE;'>#胃肠间质瘤#</a>, objectTitle=2021V1美国国家综合癌症网络胃肠间质瘤诊疗指南更新解读, objectType=guider, longId=16305, objectId=770581c0023666f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=770581c0023666f0, replyNumber=0, likeNumber=55, createdTime=2022-08-27, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=770581c0023666f0, moduleTitle=2021V1美国国家综合癌症网络胃肠间质瘤诊疗指南更新解读, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=770581c0023666f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1191625, encodeId=2a41119162570, content=<a href='/topic/show?id=97b783362ae' target=_blank style='color:#2F92EE;'>#胃肠间质瘤#</a><a href='/topic/show?id=c14d5638971' target=_blank style='color:#2F92EE;'>#指南#</a>, objectTitle=CSCO胃肠间质瘤诊疗指南, objectType=open_course, longId=844, objectId=844, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211228/1640668944981_5573504.jpg, objectUrl=https://open.medsci.cn/study/be5e58844583, replyNumber=0, likeNumber=68, createdTime=2022-02-09, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be5e58844583, moduleTitle=CSCO胃肠间质瘤诊疗指南, moduleType=open_course, hrefUrl=https://open.medsci.cn/study/be5e58844583)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

胃肠间质瘤

2020-05-29发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#实体瘤# #胃肠间质瘤# #NTRK3#

“绘”解读真报告丨胃肠间质瘤患者检出NTRK3融合，实体瘤1299基因助力临床诊疗

2024-01-22发表于陕西省

(审核中...)

前往app查看评论内容

瑞培替尼治疗3次或以上治疗后的晚期#胃肠间质瘤#

2023 NICE 技术鉴定指导意见：瑞培替尼治疗3次或以上治疗后的晚期胃肠道间质瘤[TA881]

2023-05-04发表于上海

(审核中...)

前往app查看评论内容

基于STATs磷酸化诱导TAMs重塑探究#黄芪多糖#协同#卡博替尼#抗#胃肠间质瘤#耐药机制

基于STATs磷酸化诱导TAMs重塑探究黄芪多糖协同卡博替尼抗胃肠间质瘤耐药机制

2023-04-16发表于香港

(审核中...)

前往app查看评论内容

#胃肠间质瘤#

田艳涛：2022版胃肠间质瘤指南解读

2022-09-02

循证小兵 (审核中...)

前往app查看评论内容

#CAR-T治疗##神经内分泌肿瘤#和#胃肠间质瘤#的安全靶点——CDH17（LI#钙粘蛋白#）

Nature Cancer：CAR-T治疗神经内分泌肿瘤和胃肠间质瘤的安全靶点——CDH17（LI钙粘蛋白）

2022-08-27

循证小兵 (审核中...)

前往app查看评论内容

#胃肠间质瘤#

胃肠间质瘤基因检测与临床应用的中国专家共识(2021版)

2022-08-27

循证小兵 (审核中...)

前往app查看评论内容

#胃肠间质瘤#

2021V1美国国家综合癌症网络胃肠间质瘤诊疗指南更新解读

2022-08-27

医者仁者 (审核中...)

前往app查看评论内容

#胃肠间质瘤##指南#

CSCO胃肠间质瘤诊疗指南

2022-02-09

科室
- - 订阅+
  - 更多科室
工具
服务